Changjun Yue, MD, PhD

Dr. Changjun Yue is board-certified in hematopathology, molecular genetic pathology and anatomic and clinical pathology. He has been working at Labcorp for more than 20 years. Changjun has built resilient pathologist and scientist teams in both Los Angeles and Shanghai. In his current role, he serves as the CAP/CLIA laboratory director for the Los Angeles Anatomic Pathology and Histology Center of Excellence, and has created the global Complete Pathological Response program. Changjun is a Principal Investigator in hundreds of CDx trials and reviews cases in anatomic pathology, flow cytometry, hematopathology and molecular genetic pathology (primarily fluorescent in situ hybridization, or FISH cases). 

Changjun completed his fellowship in hematopathology at the UCLA Medical Center and residency in anatomic and clinical pathology at Harbor-UCLA. He also completed a Lymphoma Fellowship with Dr. Elaine Jaffe at NIH. He obtained his doctorate in Molecular Pharmacology and Toxicology from the University of Southern California, and a master of science in Clinical Trials from the Institute of Pharmacology and Toxicology (Beijing).